A new trading day began on Friday, with Caribou Biosciences Inc (NASDAQ: CRBU) stock price down -4.31% from the previous day of trading, before settling in for the closing price of $1.16. CRBU’s price has ranged from $0.66 to $3.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 11.54%. Meanwhile, its annual earnings per share averaged 4.47%. With a float of $80.97 million, this company’s outstanding shares have now reached $93.00 million.
The extent of productivity of a business whose workforce counts for 147 workers is very important to gauge. In terms of profitability, gross margin is 73.03%, operating margin of -2161.63%, and the pretax margin is -1954.67%.
Caribou Biosciences Inc (CRBU) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Caribou Biosciences Inc is 12.94%, while institutional ownership is 50.40%. The most recent insider transaction that took place on Mar 14 ’25, was worth 20,400. In this transaction President and CEO of this company bought 20,000 shares at a rate of $1.02, taking the stock ownership to the 3,369,395 shares. Before that another transaction happened on Feb 21 ’25, when Company’s Chief Legal Officer sold 3,564 for $1.35, making the entire transaction worth $4,811. This insider now owns 443,502 shares in total.
Caribou Biosciences Inc (CRBU) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 4.47% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 11.15% during the next five years compared to -33.41% drop over the previous five years of trading.
Caribou Biosciences Inc (NASDAQ: CRBU) Trading Performance Indicators
Here are Caribou Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.63. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.41.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.62, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach -1.40 in one year’s time.
Technical Analysis of Caribou Biosciences Inc (CRBU)
The latest stats from [Caribou Biosciences Inc, CRBU] show that its last 5-days average volume of 1.22 million was superior to 1.18 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 52.41%. Additionally, its Average True Range was 0.10.
During the past 100 days, Caribou Biosciences Inc’s (CRBU) raw stochastic average was set at 49.45%, which indicates a significant increase from 41.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 103.17% in the past 14 days, which was higher than the 89.90% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9268, while its 200-day Moving Average is $1.5125. Now, the first resistance to watch is $1.1500. This is followed by the second major resistance level at $1.1900. The third major resistance level sits at $1.2200. If the price goes on to break the first support level at $1.0800, it is likely to go to the next support level at $1.0500. The third support level lies at $1.0100 if the price breaches the second support level.
Caribou Biosciences Inc (NASDAQ: CRBU) Key Stats
With a market capitalization of 103.24 million, the company has a total of 93,005K Shares Outstanding. Currently, annual sales are 9,990 K while annual income is -149,110 K. The company’s previous quarter sales were 2,350 K while its latest quarter income was -39,990 K.
